Monographie - Pentamidine isetionate

Poslední aktualizace :
08/05/2024

Pentamidine isetionate

Cheminė sandara

Prekinis pavadinimas

Trade names are indicative and excipients composition can be different depending on the country and manufacturers

DBL Pentamidine isetionate	Malaizija
Manicare	Argentina
Nebupent	Jungtinės Amerikos Valstijos
Pentacarinat	Austrija, Belgija, Danija, Didžioji Britanija, Graikija, Ispanija, Italija, Kolumbija, Liuksemburgas, Naujojoje Zelandijoje, Olandija, Prancūzija, Suomija, Švedija, Šveicarija, Vokietija
Pentam	Jungtinės Amerikos Valstijos
Pentamidina	Argentina, Ispanija
Pentamidine isethionate	Australija, Jungtinės Amerikos Valstijos, Kanada, Malaizija
Pentamina	Portugalija

Bibliografija : Pentamidine isetionate

	Tipas	Leidinys
36	Žurnalas	Alex S, Gupta SL, Minor JR, Turcovski-Corrales S, Gallelli JF, Taub D, Piscitelli SC. Compatibility and activity of aldesleukin (recombinant interleukin-2) in presence of selected drugs during simulated Y-site administration: Evaluation of three methods. Am J Health-Syst Pharm 1995 ; 52: 2423-2426.
73	Žurnalas	Lor E, Takagi J. Visual compatibility of foscarnet with other injectable drugs. Am J Hosp Pharm 1990 ; 47: 157-159.
198	Žurnalas	Gayed AA, Kheshary PR, Hinkle RL. Visual compatibility of diltiazem injection with various diluents and medications during simulated Y-site injection. Am J Health-Syst Pharm 1995 ; 52: 516-520.
275	Žurnalas	Lewis JD, El-Gendy A. Cephalosporin-pentamidine isethionate incompatibilities. Am J Health-Syst Pharm 1996 ; 53: 1461-1462.
337	Žurnalas	Bashaw ED, Amantea MA, Minor JR, Galleli JF. Visual compatibility of zidovudine with other drugs during simulated Y-site administration. Am J Hosp Pharm 1988 ; 45: 2532-2533.
424	Žurnalas	De NC, Alam AS, Kapoor JN. Stability of pentamidine isethionate in 5% dextrose and 0.9% sodium chloride injections. Am J Hosp Pharm 1986 ; 43: 1486-1488.
496	Žurnalas	Lor E, Sheybani T, Takagi J. Visual compatibility of fluconazole with commonly used injectable drugs during simulated Y-site administration. Am J Hosp Pharm 1991 ; 48: 744-746.
604	Laboratorija	Stabilité des médicaments dans l'Intermate® SV50, 100, 200 Baxter 1998
1135	Žurnalas	Baltz JK, Kennedy P, Minor JR, Gallelli J. Visual compatibility of foscarnet with other injectable drugs during simulated Y-site administration. Am J Hosp Pharm 1990 ; 47: 2075-2077.
1235	Žurnalas	Leigh PH, Buddle GC. Pentamidine infusion stability. Br J Pharm Pract 1988 ; 10: 22-23.
1625	Žurnalas	Trissel LA, Saenz C, Williams YW, Ingram D. Incompatibilities of lansoprazole injection with other drugs during simulated Y-site coadministration. Int J Pharm Compound 2001 ; 5: 314-321.
1925	Žurnalas	Trissel LA , Williams KY, Gilbert DL. Compatibility screening of linezolid injection during simulated Y-site administration with other drugs and infusion solutions. J Am Pharm Assoc 2000 ; 40: 515-519.
3543	Laboratorija	Ceftazidime – Summary of Product Characteristics Wockhardt 2013
3559	Laboratorija	Pentamidine diiséthionate (Pentacarinat®) - Résumé des caractéristiques du produit Sanofi Aventis France 2013
3560	Laboratorija	Linezolid (Zyvox®) - Summary of Product Characteristics Pharmacia 2013
3662	Laboratorija	Foscavir (Foscarnet®) - Summary of Product Characteristics Clinigen 2014

Mentions Légales